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Efavirenz is used for highly active antiretroviral therapy for the treatment of human immunodeficiency virus type-1. We 
studied the effect of chronic administration of efavirenz on the inferior colliculus of adult Wistar rats. Rats of both 
sexes (n = 16) were randomly assigned into treatment (n = 8) and control (n = 8) groups. The treatment group received 
600 mg/70 kg body weight of efavirenz dissolved in distilled water daily for 30 days through an orogastric tube, and con-
trols received distilled water. The rats were sacrificed on the 31st day of the experiment. We found that treated rats 
had cellular degenerative changes such as a sparse cellular population, hypertrophy, microcystic changes, and vacuola-
tion in the stroma of the inferior colliculus in treated rats compared with controls. Chronic administration of efavirenz 
may adversely affect the auditory system by affecting the microanatomy of the inferior colliculus of adult Wistar rats.
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Introduction
Efavirenz is an antiretroviral drug that belongs to 
the class of drugs called nonnucleoside reverse tran-
scriptase inhibitors used as part of highly active 
antiretroviral therapy (HAART) for the treatment 
of human immunodeficiency virus (HIV) type-1.1 
Efavirenz is effective in many combination regimes 
for the treatment of HIV infection, in both previ-
ously untreated individuals and in those undergoing 
treatment. It has been successfully combined with 
nucleoside analogs consisting of lamivudine or emtri-
citabine plus abacavir, didanosine, stavidine, teno-
fovir or zidovudine to achieve virological suppression 
in a high percentage of recipients.2,3 Most antiviral 
agents do not efficiently penetrate the blood brain 
barrier or are actively transported out of the central 
nervous system.4 Even after antiviral treatment 
successfully controls the virus in the treatment 
compartments, the central nervous system may 
suffer continued damage induced by HIV infection.5 
Efavirenz may be taken once a day without a meal, 
and it can penetrate the central nervous system and 
spinal fluids.6,7
Efavirenz has emerged as a cornerstone of HAART 
regimens. However, some adverse effects in the 
central nervous system have been associated with 
efavirenz.8 The most common central nervous sys-
tem effects include confusion, insomnia, abnormal 
vivid dreams, dizziness and headaches. The side 
effect profile of the drug is generally regarded as 
satisfactory, despite some conflicting study results 
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Figure 1 Control section of the inferior colliculus 
(hematoxylin and eosin, 400×).
in the medical literature, as well as conflicting stud-
ies from patients and physicians regarding the neu-
ropsychiatric problems associated with efavirenz.9 
Lipodystrophy, moderate or severe pain, abnormal 
vision, arthralgia, asthenia, dyspnea, gynecomastia, 
myalgia, myopathy, and tinnitus have been reported 
with efavirenz use.1
The inferior colliculus is the obligatory midbrain 
synaptic target of the ascending auditory pathway 
in which the contralateral ear is primarily repre-
sented.10 The inferior colliculus is essential for nor-
mal hearing and for the startle reflex. It receives its 
ascending input mainly from the contralateral coch-
lear nucleus and the superior olive, and it sends 
axons to the medial geniculate body.10
Cortical structures such as the medial and lateral 
geniculate bodies, and inferior and superior colliculi 
exhibit higher glucose use than other structures.11 
There is a correlation between functional activity and 
metabolic rate in the visual and auditory system.11 
Since efavirenz crosses the blood brain barrier, it 
is important to determine its effect on the inferior 
colliculus. It is probable that the adverse effects 
of efavirenz on hearing, such as tinnitus, may be due 
to direct effects of efavirenz on the inferior collic-
ulus. The present study aimed to elucidate the ef-
fects of chronic administration of efavirenz on the 
inferior colliculus of adult Wistar rats.
Materials and Methods
Animals
Adult Wistar rats of both sexes (n = 16), with an aver-
age weight of 200 g, were randomly assigned into two 
groups: control (n = 8) and treatment (n = 8). The rats 
were obtained and maintained in the Animal Holding 
of the Department of Anatomy, School of Basic Medi-
cal Sciences, University of Benin, Benin City, Edo 
State, Nigeria. They were fed with grower’s mash 
obtained from Edo Feeds and Flour Mill Limited (Ewu, 
Edo State, Nigeria) and given liberal access to water. 
Efavirenz was obtained from the President’s Emer-
gency Plan for Aids Relief unit, University of Benin 
Teaching Hospital, Benin City, Edo State, Nigeria.
Drug administration
The rats in the treatment group received the recom-
mended daily dosage of 600 mg/70 kg body weight 
of efavirenz dissolved in distilled water for 30 days 
through orogastric tube administration, while the 
control rats received an equal volume of distilled 
water through the same route and for the same 
period of time. The rats were sacrificed by cervi-
cal dislocation on the 31st day of the experiment. 
The skull was opened using bone forceps to expose 
the brain of the rats and the inferior colliculus was 
quickly dissected out and fixed in 10% formal sa-
line for routine histological techniques.
Histological study
The tissues were dehydrated in an ascending grade 
of alcohol (ethanol), cleared in xylene, and then 
embedded in paraffin wax. Serial sections 7 μm in 
thickness were obtained using a rotatory microtome. 
The deparaffinized sections were stained routinely 
with hematoxylin and eosin.12
Photomicrographs of the results were obtained 
using a research photographic microscope in the 
Department of Anatomy, School of Basic Medical 
Sciences, University of Benin, Benin city, Edo State, 
Nigeria.
Results
Sections of the inferior colliculus from control ani-
mals showed normal histological features with the 
neurons appearing distinct and within the normal 
range of sizes. Neuronal and glial cells appeared 
normal, and no vacuolation in the stroma of the 
sections was observed (Figure 1).
The inferior colliculus of the treated group 
showed cellular degenerative changes such as a 
sparse cellular population, hypertrophy, microcystic 
changes, and vacuolation in the stroma compared 
with the control group (Figure 2).
Discussion
Our study showed that efavirenz treatment resulted 
in various cellular degenerative changes such as a 
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sparse cellular population, hypertrophy, microcystic 
changes and vacuolation in the stroma of the infe-
rior colliculus compared with controls.
Neuronal degeneration has been reported to re-
sult in cell death, which consists of two types, apo-
ptotic and necrotic cell death. These two types of cell 
death differ morphologically and biochemically.13 
Pathological or accidental cell death is regarded as 
necrotic, and can result from extrinsic insults to the 
cell such as osmotic, thermal, toxic, and traumatic 
effects.14 It has been reported that cell death in 
response to neurotoxins might trigger an apoptotic 
death pathway within brain cells.15 Cell death from 
neurotoxins occurs as a controlled event involving 
a genetic program in which caspase enzymes are 
activated.15 The process of cellular necrosis in-
volves disruption of the structural and functional 
integrity of the membranes. Cellular necrosis is 
not induced by stimuli intrinsic to cells as in pro-
grammed cell death, but by an abrupt environ-
mental perturbation and departure from normal 
physiological conditions.16 Further investigation 
into the actual mechanism by which efavirenz in-
duces neuronal degeneration in the inferior collic-
ulus of adult rats is required.
Extensive cell death in the central nervous system 
is present in all neurodegenerative diseases.16 The 
type of nerve cell loss and the particular part of the 
brain affected dictate the symptoms associated 
with an individual disease.16 In our study, efavirenz 
may have acted as a toxin to cells of the inferior 
colliculus, affecting their cellular integrity and caus-
ing defects in membrane permeability and cell vol-
ume homeostasis.
In cellular necrosis, the rate of progression de-
pends on the severity of the environmental insult. 
The greater the severity of the insult, the more rapid 
the progression of neuronal injury.17 This principle 
holds true for toxicological insults to the brain and 
other organs.16 Prime candidates for inducing massive 
cell destruction observed in neurodegeneration are 
neurotoxins.15 These substances may be present in 
small amounts in the environment, or even naturally 
occurring chemicals such as glutamate used by the 
brain as transmitter’s substances.15 When glutamate 
is present at a critical level it can be toxic to brain 
cells.15 Our study results suggested that prolonged 
administration of efavirenz resulted in increased 
toxic effects on the inferior colliculus. The decrease 
in cellular population observed in this study may 
have resulted from cell death caused by the toxic 
effects of efavirenz. Similarly, it has been reported 
that chronic administration of chloroquine results in 
cellular degenerative changes, a sparse cellular pop-
ulation and vacuolation appearing in the stroma with 
some autophagic vacuoles in the inferior colliculus 
and medial geniculate body of adult Wistar rats.18,19
The microcystic changes and vacuolation observed 
in the stroma of the inferior colliculus in this experi-
ment may have been due to efavirenz interference, 
since it is known to cross the blood brain barrier, and 
thus access cells of the brain. The results observed 
in this experiment may have been due to the adverse 
effects of efavirenz on the inferior colliculus, since 
it has been reported that chronic administration of 
efavirenz affects the weight of the brain and infe-
rior colliculus in adult Wistar rats.20 This previous 
study showed that there was a significant decrease 
(p < 0.05) in dry brain weight, and an increase in the 
relative dry brain weight of the treatment group 
compared with controls. There was also a significant 
increase (p < 0.05) in the relative weight of the dry 
inferior colliculus as well as per total dry brain weight 
in the treatment group compared with controls.20 
Since the neurons of the central nervous system are 
affected by efavirenz, it is probable that the results 
obtained in our experiment may have been due to 
the neurotoxic effects of efavirenz on the neuronal 
cells of the inferior colliculus of adult Wistar rats.
Ischemic or pharmacologic disruption of cellular 
transporters can cause swelling of the brain paren-
chyma. Under such conditions, there is a net shift 
of water from the extracellular space to the interior 
of the brain cells.21 Cytotoxic edema usually involves 
intracellular swelling of glial, endothelial, and neu-
ronal cells.21 The microcystic changes and vacuola-
tion in the stroma of the treated inferior colliculus 
reported in our experiment may have been due to 
the neurotoxic effect of efavirenz on cells of the 
inferior colliculus. Regulation of brain water content, 
and therefore, volume, is critical for maintaining 
the intracranial pressure within tolerable limits.21 
Since efavirenz affects the weight of the brain and 
that of the inferior colliculus in adult Wistar rats,20 
in our study, efavirenz could have acted as a toxin to 
Figure 2 Treated section of inferior colliculus (hema-
toxylin and eosin, 400×).
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cells of the inferior colliculus, thus affecting their 
cellular integrity and causing a defect in membrane 
permeability and cell volume homeostasis. The 
prime candidates for inducing a massive increase 
in cell volume observed in neurodegeneration are 
neurotoxins.22
As brain tissue shrinks or swells, as reported in 
this study, the activity of cellular transporters is 
modified by up-regulation or down-regulation such 
as in the case of hyponatremia or hypernatremia.21 
Ischemia or pharmacological disruption of cellular 
transporters can cause swelling of parenchyma of the 
brain and in the inferior colliculus. Pharmacological 
disruption of the inferior colliculus caused by efa-
virenz was a cardinal feature of our experiment. 
However, there are many different causes of cellular 
swelling, including drug poisoning, water intoxica-
tion, hypoxia, and acute hyponatremia.21 Under 
such conditions, there is a net shift of water from 
the extracellular space to the interior of the brain 
cells.21 In our experiment, we observed intracellular 
swelling of glial, endothelial and neuronal cells.21 
Brain swelling along with severe cytotoxic edema 
may lead to a marked reduction in the size of the 
ventricular system and basal cisterns.21
The toxic effects of efavirenz on the microanat-
omy and weight of the inferior colliculus on rats high-
lights the potential neurological symptoms, such as 
lipodystrophy, moderate or severe pain, abnormal 
vision, arthralgia, asthenia, dyspnea, gynecomastia, 
myalgia, myopathy and tinnitus reported among 
patients receiving efavirenz treatment.1
This study revealed that chronic administration of 
efavirenz resulted in degenerative cellular changes 
such as a sparse cellular population, hypertrophy, 
microcystic changes, and vacuolation in the stroma 
of the treated inferior colliculus compared with 
controls in adult Wistar rats. These data may indi-
cate an effect on function of the auditory system of 
the inferior colliculus. Further studies are required 
to corroborate our observations on the inferior 
colliculus.
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